
PR Newswire
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or meta...
MATSUSAKA, Japan, Dec. 11, 2025 /PRNewswire/ -- SINEXCEL (300693.SZ) has successfully completed the ...
Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Ther...
TAIPEI, Dec. 11, 2025 /PRNewswire/ -- Taiwan boasts an extensive island-circling cycling route netwo...
NEW YORK and DAEJEON, South Korea, Dec. 11, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPO...
NEW YORK and DAEJEON, South Korea, Dec. 11, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPO...
Leading solar manufacturer supports wildlife rehabilitation through renewable energy donation KETTER...
HONG KONG, Dec. 11, 2025 /PRNewswire/ -- I. Elite Certifications and Insurmountable Market Barriers ...
HONG KONG and LONDON, Dec. 11, 2025 /PRNewswire/ -- CONDUCA Consulting ("CONDUCA") and PayTech Consu...
MOUNT PEARL, NL and SYDNEY, Dec. 11, 2025 /PRNewswire/ -- Solace Power Inc. ("Solace") and Ne...
SINGAPORE and GELEPHU, Bhutan, Dec. 11, 2025 /PRNewswire/ -- Gelephu Mindfulness City (GMC) is rapid...
K-Healthtech Firm Targets Rapid Global Scale-Up with Drug-Free Nasal-Care Innovation SINGAPORE and S...


ภาษาไทย
English